Edition:
United States

Pfizer Receives European Approval For Zirabev, A Biosimilar To Avastin


Tuesday, 19 Feb 2019 09:32am EST 

Feb 19 (Reuters) - Pfizer Inc ::PFIZER RECEIVES EUROPEAN APPROVAL FOR ZIRABEV (BEVACIZUMAB), A BIOSIMILAR TO AVASTIN.EC APPROVAL FOR ZIRABEV IS BASED ON A COMPREHENSIVE SUBMISSION PACKAGE WHICH DEMONSTRATED BIOSIMILARITY OF ZIRABEV AND ORIGINATOR PRODUCT.